Umoja Biopharma
Highly Engaged Employees
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1150 Eastlake Ave E Ste 400, Seattle, Wa...Website
www.umoja-biopharma.comRevenue
$40.2 MillionIndustry
About Umoja Biopharma
Umoja Biopharma, Inc. is a preclinical stage company advancing an entirely new approach to immunotherapy designed to retool a patient's immune system in vivo. Founded based on pioneering work performed at Seattle Children's Research Institute and Purdue University, Umoja's novel approach is powered by integrated cellular immunotherapy technologies including the VivoVec in vivo delivery platform, the RACR/CAR in vivo cell expansion/control platform, and the TumorTag targeting platform. Designed from the ground up to work together, these platforms are being developed to create and harness a powerful immune response in the body to directly, safely, and controllably attack cancer. Umoja believes that its approach can provide broader access to the most advanced immunotherapies and enable more patients to live better, fuller lives.Explore more
SIC Code 87,873NAICS Code 54,541Show moreUmoja Biopharma Org Chart
Show More
Compare Similar Companies to Umoja Biopharma
Compare insights from companies similar to Umoja Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Umoja Biopharma Tech Stack
A closer look at the technologies used by Umoja Biopharma
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Umoja Biopharma
Sign Up For FreeTo access detailed company insights
Umoja Biopharma, Inc. is a preclinical stage company advancing an entirely new approach to immunotherapy designed to retool a patient's immune system in vivo. Founded based on pioneering work performed at Seattle Children's Research Institute and Purdue University, Umoja's novel approach is powered by integrated cellular immunotherapy technologies... Read More
